Showing results (1171-1180 of 1,211) with videos related to
Sort By:
Pageof 122
Cell|February 10, 2015
Chromothriptic cure of WHIM syndromeDavid H McDermott, Ji-Liang Gao, Qian Liu, et al.The British Journal of Psychiatry : the Journal of Mental Science|June 16, 2025
Linking prolonged childhood and adolescent loneliness to schizophrenia spectrum disorders: results from EU-GEI studyÁlvaro Andreu-Bernabeu, Javier González-Peñas, Alberto Mora, et al.Oncogene|October 24, 2024
USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancerMichaela Reissland, Oliver Hartmann, Saskia Tauch, et al.Molecular Genetics and Metabolism|May 7, 2015
Expanding the clinical and molecular characteristics of PIGT-CDG, a disorder of glycosylphosphatidylinositol anchorsChristina Lam, Gretchen A Golas, Mariska Davids, et al.Nature Communications|August 6, 2021
Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathyRuth Jinfen Chai, Hendrikje Werner, Peter Yiqing Li, et al.Blood|September 24, 2013
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantationJames N Kochenderfer, Mark E Dudley, Robert O Carpenter, et al.Frontiers in Immunology|November 29, 2023
The impact of the comorbid seizure/epilepsy on the health related quality of life in people with multiple sclerosis: an international multicentric studyJelena Drulovic, Tatjana Pekmezovic, Olivera Tamas, et al.The Journal of Clinical Investigation|July 3, 2023
Human endogenous retrovirus K contributes to a stem cell niche in glioblastomaAshish H Shah, Sarah R Rivas, Tara T Doucet-O'Hare, et al.JAMA Oncology|September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled TrialDickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.Pageof 122